Cantor Fitzgerald analyst Joseph France maintained a Hold rating on Acadia Healthcare (ACHC) today and set a price target of $39. The company’s shares closed yesterday at $32.05.
France observed:
“We rate ACHC Neutral primarily to reflect our view of the uncertainty associated with the recovery of its U.K. business, which accounts for 40% of the company’s revenue. $39 price target is based on comparable-company analysis and our DCF. The Disclosure Section may be found on pages 3 – 4.Valuation Our $39 price target reflects our reservations about the company’s ability to grow both organically and through acquisitions.”
According to TipRanks.com, France is a 5-star analyst with an average return of 9.0% and a 57.9% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and Addus Homecare Corp.
Currently, the analyst consensus on Acadia Healthcare is a Moderate Buy with an average price target of $40, a 24.8% upside from current levels. In a report issued on November 7, Credit Suisse also maintained a Hold rating on the stock with a $39 price target.
.
See today’s analyst top recommended stocks >>
Based on Acadia Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly net profit of $46.23 million. In comparison, last year the company had a net profit of $45.62 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Acadia Healthcare Co., Inc. engages in the provision of behavioral healthcare services. It operates through the following segments: United States (U.S.) Facilities and the United Kingdom (U.K.) Facilities, and Corporate and Other.
